Takai Shinji | Department Of Pharmacology Osaka Medical College
スポンサーリンク
概要
関連著者
-
Makino H
Department Of Medicine And Clinical Science Okayama University Graduate School Of Medicine And Denti
-
Matsubara Hiroaki
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Matsuoka Hiroaki
大阪大学 医学系研究科老年･腎臓内科学
-
Sawada Takahisa
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Shiraishi Jun
Department of Cardiology, Kyoto First Red Cross Hospital
-
Muratani H
Department Of Clinical Pharmacology And Therapeutics Tohoku University
-
Kohno Yoshio
Department of Cardiology, Kyoto First Red Cross Hospital
-
Nakamura T
Second Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Matsubara Hiroaki
公立南丹病院 循環器内科
-
Nakamura Takeshi
Department Of Cardiovascular Medicine Nantan General Hospital
-
Furukawa Keizo
Department of Cardiology, Kyoto City Hospital
-
Katamura Maki
AMI-Kyoto Multi-Center Risk Study Group
-
Nakamura Takeshi
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Yamada Hiroyuki
Ami-kyoto Multi-center Risk Study Group
-
Matsubara Hiroaki
京都府立医科大学 循環器内科学
-
Yokoi Hirokazu
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Matsuo H
Department Of Internal Medicine Circulatory And Body Fluid Regulation Faculty Of Medicine University
-
Okada Takashi
Department of Cardiology, Kyoto First Red Cross Hospital
-
Masaki Hiroya
The Cardiovascular Center Kansai Medical University
-
Hori Masatsugu
大阪大学 大学院医学系研究科内科系臨床医学専攻核医学講座
-
Shima Takatomo
Department of Cardiology, Kyoto First Red Cross Hospital
-
Yasue H
Kumamoto Univ. School Of Medicine
-
Yoshioka Katsunobu
Department of Internal Medicine, Osaka City General Hospital
-
Matsumuro Akiyoshi
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Shirayama Takeshi
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Nishimoto Masayoshi
Department of Emegency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Furukawa Keizo
AMI-Kyoto Multi-Center Risk Study Group
-
Kitamura Makoto
AMI-Kyoto Multi-Center Risk Study Group
-
Matoba Satoaki
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
YAMADA Hiroyuki
Department of Materials Engineering, Graduate school of Engineering, The University of Tokyo
-
Tatsumi Tetsuya
Kyoto Prefectural University Of Medicine
-
Tatsumi Tetsuya
Department Of Cardiovascular Medicine Nantan General Hospital
-
Ishihara Tadashi
First Department of Internal Medicine, Osaka Medical College
-
Makino Hirofumi
Okayama Univ. Graduate School Of Medicine Dentistry And Pharmaceutical Sci. Okayama Jpn
-
Okigaki Mitsuhiko
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Mokuno Hiroshi
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
Hayashi T
Third Dep. Of Medicine Osaka Medical Coll. Jpn
-
Hayashi Tetsuya
大阪医科大学 薬理学教室
-
Horio Masaru
大阪大学 医学系研究科内科学講座腎臓内科
-
ANDO Katsuyuki
University of Tokyo
-
KINOSHITA Noriyuki
Department of Cardiology, Kouseikai Takeda Hospital
-
NISHIKAWA Susumu
Department of Cardiovascular Medicine, Nantan General Hospital
-
Hoshiga Masaaki
First Department of Internal Medicine, Osaka Medical College
-
Kinoshita Noriyuki
AMI-Kyoto Multi-Center Risk Study Group
-
Kimura Shinzo
AMI-Kyoto Multi-Center Risk Study Group
-
Shiraishi Jun
AMI-Kyoto Multi-Center Risk Study Group
-
Kohno Yoshio
AMI-Kyoto Multi-Center Risk Study Group
-
Amano Katsuya
University Of Tokyo
-
Amano Katsuya
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Nishikawa Susumu
Department Of Cardiovascular Medicine Nantan General Hospital
-
Mori Yasukiyo
Cardiovascular Division Department Of Medicine Ii Kansai Medical University
-
Mori Yasukiyo
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine
-
Hayashi Tetsuya
Third Department of Internal Medicine, Osaka Medical College
-
Okigaki Mitsuhiko
京都府立医科大学 循環器･腎臓内科学
-
Kitamura Makoto
Department Of Cardiology Kyoto Second Red Cross Hospital
-
TANAKA Kazuhiko
Department of Clinical Pharmacology & Pharmacokinetics, Osaka University of Pharmaceutical Sciences
-
Iwasaka Toshiji
Department of Medicine 2 Kansai Medical University
-
Hori Masatsugu
大阪大学 医学系研究科循環器内科学
-
Hadase Mitsuyoshi
Department of Cardiology, Saiseikai Shigaken Hospital
-
YOKOYAMA Mitsuhiro
Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe Universit
-
Amano Katsuya
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine
-
AZUMA Akihiro
Department of Cardiology, National Shiga Hospital
-
KEIRA Natsuya
Department of Cardiovascular Medicine, Nantan General Hospital
-
Nishizawa Shinya
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Shiraishi Hirokazu
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Miyanaga Hajime
AMI-Kyoto Multi-Center Risk Study Group
-
Yamada Chihiro
AMI-Kyoto Multi-Center Risk Study Group
-
Kuriyama Takuya
AMI-Kyoto Multi-Center Risk Study Group
-
Shiga Koji
AMI-Kyoto Multi-Center Risk Study Group
-
Yamahara Yasuhiro
AMI-Kyoto Multi-Center Risk Study Group
-
Sakai Ryuta
AMI-Kyoto Multi-Center Risk Study Group
-
Nishio Manabu
AMI-Kyoto Multi-Center Risk Study Group
-
Okigaki Mitsuhiko
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine
-
Kitaura Y
Third Department Of Internal Medicine Osaka Medical College
-
Koito Hitoshi
The Cardiovascular Center Kansai Medical University
-
Makino Hirofumi
岡山大学 医歯学総合研究科腎･免疫･内分泌代謝内科学
-
Makino Hirofumi
大阪大学 医学系研究科老年･腎臓内科学
-
Kitaura Yasushi
Department Of Cardiovascular Science And Medicine Chiba University Graduate School Of Medicine
-
OKADA Noriyuki
Department of Kidney Disease and Hypertension, Osaka General Medical Center
-
Horio Masaru
琉球大学医学部附属病院 血液浄化療法部
-
Okada Noriyuki
Department Of Nephrology And Hypertension Osaka City General Hospital
-
Okada Noriyuki
大阪市立総合医療センター 内科
-
Morikawa Takashi
Department of Internal Medicine, Osaka City General Hospital
-
MATSUBARA Hiroaki
Kyoto Prefectural University of Medicine
-
KUMAGAI Hiroo
National Defense Medical College
-
Sakamoto Kenji
熊本大学 医学教育部循環器病態学
-
OKAMOTO Ryoichi
Department of Microbiology, Kitasato University School of Medicine
-
Koide Shunichi
熊本大学 循環器内科
-
IRIE Hidekazu
Department of Cardiology, Kouseikai Takeda Hospital
-
TATSUMI Tetsuya
Department of Cardiovascular Medicine, Nantan General Hospital
-
Matsui Akihiro
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Tatsumi Tetsuya
AMI-Kyoto Multi-Center Risk Study Group
-
Harada Yoshiaki
AMI-Kyoto Multi-Center Risk Study Group
-
Kitaura Y
Third Department Of Medicine Osaka Medical College
-
Ukimura Akira
Department Of Internal Medicine Iii Osaka Medical College
-
SOHMIYA Koichi
Third Department of Internal Medicine, Osaka Medical College
-
Hyogo Masayuki
Department of Cardiology, Kyoto Second Red Cross Hospital
-
Kudoh Sumiyo
Department Of Internal Medicine Iii Osaka Medical College
-
Sohmiya Koichi
Department Of Internal Medicine Iii Osaka Medical College
-
Sohmiya Koichi
Third Department Of Internal Medicine Osaka Medical College
-
Ukimura Akira
Third Department Of Internal Medicine Osaka Medical College
-
Sawada Takahisa
AMI-Kyoto Multi-Center Risk Study Group
-
Arihara Masayasu
AMI-Kyoto Multi-Center Risk Study Group
-
Hyogo Masayuki
AMI-Kyoto Multi-Center Risk Study Group
-
Yagi Takakazu
AMI-Kyoto Multi-Center Risk Study Group
-
Shima Takatomo
AMI-Kyoto Multi-Center Risk Study Group
-
Okada Takashi
AMI-Kyoto Multi-Center Risk Study Group
-
Nakamura Takeshi
AMI-Kyoto Multi-Center Risk Study Group
-
Matoba Satoaki
AMI-Kyoto Multi-Center Risk Study Group
-
Shirayama Takeshi
AMI-Kyoto Multi-Center Risk Study Group
-
Matsubara Hiroaki
AMI-Kyoto Multi-Center Risk Study Group
-
Matsuda Hikaru
Cardiovascular Division Osaka Polici Hospital
-
IMAI Yumiko
Department of Biological Informatics and Experimental Therapeutics, the Global COE program, Akita Un
-
SUGIYAMA Tetsuya
Department of Removable Prosthodontics and Gerodontology, Tokyo Dental College
-
Taniguchi Norimasa
Department of Cardiology, Sakurakai Takahashi Hospital
-
Matsubara Kinya
Department of Cardiology, Kyoto City Hospital
-
Nakahara Yoshifumi
Department of Cardiology, Saiseikai Shigaken Hospital
-
Nakamura Takashi
Department of Cardiology, Saiseikai Shigaken Hospital
-
KAJIMOTO Yoshinaga
Department of Neurosurgery, Osaka Medical College
-
Kioka Kiyohide
Department of Hepatology, Osaka City General Hospital
-
Yamagami Keiko
Department of Internal Medicine, Osaka City General Hospital
-
Tomino Y
Department Of Basic Medical Research And Education Ehime University Graduate School Of Medicine
-
FUJITA Tadashi
Department of Orthodontics and Craniofacial Developmental Biology, Hiroshima University, Graduate Sc
-
HORIO Takeshi
National Cardiovascular Center
-
Hoshikawa Yoshiko
Div. Of Molecular And Genetic Medicine Dep. Of Genetic Medicine And Regenerative Therapeutics Gradua
-
TANAKA Hidekazu
Department of Natural History Sciences, Faculty of Science, Hokkaido University
-
yaku hitoshi
Department of Cardiovascular Surgery, Kyoto Prefectural University School of Medicine
-
Tsutsumi Yoshiaki
Department of Cardiovascular Medicine, National Cardiovascular Center
-
Ariyoshi Makoto
Department of Cardiology, Kyoto City Hospital
-
IKEDA Tadashi
Department of Surgery, Keio University School of Medicine
-
Yamazaki Osamu
Department of Hepato-Biliary-Pancreatic Surgery, OsakaCity University, Graduate School of Medicine
-
Yoshida Kaoru
Department Of Cardiology Kawasaki Medical School
-
NAKAMURA Reo
Department of Cardiology, Kouseikai Takeda Hospital
-
TAKAHASHI Akihiko
Department of Cardiology, Sakurakai Takahashi Hospital
-
YAMADA Takeshi
Department of Cardiology, Kouseikai Takeda Hospital
-
MIYAI Nobuyuki
Department of Cardiology, Kouseikai Takeda Hospital
-
NOMURA Tetsuya
Department of Cardiovascular Medicine, Nantan General Hospital
-
URAKABE Yota
Department of Cardiovascular Medicine, Nantan General Hospital
-
Iwasaka Toshiji
Cardiovascular Division, Department of Medicine II, Kansai Medical University
-
Nakanishi Naohiko
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Yanishi Kenji
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Akakabe Yoshiki
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Kuroyanagi Akira
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Tsubakimoto Yoshinori
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Zushi Ryousuke
Department of Emegency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Hazui Hiroshi
Department of Emegency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Mori Toshizumi
Department of Emegency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Ohishi Yasuo
Department of Emegency Medicine, Osaka Mishima Emergency and Critical Care Center
-
Yamamoto Hiromi
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
-
KISO Yoshinobu
Institute for Health Care Science, Suntory Ltd.
-
Yaku Hitoshi
Department Of Cardiovascular Dynamics National Cardiovascular Center Research Institute
-
Yaku Hitoshi
Department Of Cardiovascular Surgery Kyoto Prefectural University Of Medicine
-
Tsutsumi Yoshiaki
Division Of Cardiology National Cardiovascular Center
-
komeda Masashi
Department of Cardiovascular Surgery, Kyoto University
-
MIYATAKE Shin-Ichi
Department of Neurosurgery, Osaka Medical College
-
KUROIWA Toshihiko
Department of Neurosurgery, Osaka Medical College
-
Tabara Yasuharu
国立循環器病センター研究所 疫学部
-
Tabara Yasuharu
西予市立野村病院 内科
-
Hirata Yasunobu
Cardiovascular Medicine University Of Tokyo
-
Tsubakihara Yoshiharu
大阪府立病院機構大阪府立急性期総合医療センター 腎臓･高血圧内科
-
Tsubakihara Yoshiharu
Department Of Nephrology Osaka Prefectural Hospital
-
Kitaura Yasushi
Third Department of Internal Medicine, Osaka Medical College
-
UKIMURA Akira
Third Department of Internal Medicine, Osaka Medical College
-
Mori Tatsuhiko
Third Department of Medicine, Osaka Medical College
-
Yokoyama Mitsuhiro
Department Of Cardiovascular Medicine Awaji Prefectural Hospital
-
Yokoyama Mitsuhiro
()
-
Tomino Yasuhiko
共立薬科大学 薬物治療学
-
INOUE Takeshi
Departments of Pathology, Osaka City General Hospital
-
IKEDA Tsunehiko
Department of Internal Medicine 2, Fukushima Medical University School of Medicine
-
Morita Hiroshi
Department of Cardiology, Shingu Munichipal Hospital
-
Kamihata Hiroshi
Department of Cardiology, Kansai Medical University Hospital
-
Tsubakimoto Yoshinori
Department Of Cardiolgy Kyoto Prefectural University Of Medicine
-
Ukimura Akira
Department Of Cardiology Shiga Medical Center For Adult Diseases
-
KOZAWA Osamu
Department of Pharmacology, Gifu University Graduate School of Medicine
-
Takahashi Hakuo
Department Of Clinical Sciences And Laboratory Medicine Kansai Medical University
-
Takahashi Hakuo
Department Of Cardiovascular Medicine Shinshu University Graduate School Of Medicine
-
Hirata Yasunobu
Department Of Cardiovascular Medicine The University Of Tokushima
-
Hirata Yasunobu
東京大学 第2内科
-
Takeda Mitsuo
Department of Cardiology, Kyoto Prefectural University School of Medicine
-
HOSHINO Atsushi
Kyoto Prefectural University of Medicine, Department of Cardiology
-
SAWADA Takahisa
Kyoto Prefectural University of Medicine, Department of Cardiology
-
MATSUDA Megumi
Kyoto Prefectural University of Medicine, Department of Cardiology
-
MIYAGAWA Sonoko
Kyoto Prefectural University of Medicine, Department of Cardiology
-
NAKAMURA Takeshi
Kyoto Prefectural University of Medicine, Department of Cardiology
-
Takeda Mitsuo
AMI-Kyoto Multi-Center Risk Study Group
-
Furukawa Keizo
AMl-Kyoto Multi-Center Risk Study Group
-
Miyanaga Hajime
AMl-Kyoto Multi-Center Risk Study Group
-
Kitamura Makoto
AMl-Kyoto Multi-Center Risk Study Group
-
Yamada Chihiro
AMl-Kyoto Multi-Center Risk Study Group
-
Tatsumi Tetsuya
AMl-Kyoto Multi-Center Risk Study Group
-
Kuriyama Takuya
AMl-Kyoto Multi-Center Risk Study Group
-
Shiga Koji
AMl-Kyoto Multi-Center Risk Study Group
-
Harada Yoshiaki
AMl-Kyoto Multi-Center Risk Study Group
-
Yamahara Yasuhiro
AMl-Kyoto Multi-Center Risk Study Group
-
Sakai Ryuta
AMl-Kyoto Multi-Center Risk Study Group
-
Katamura Maki
AMl-Kyoto Multi-Center Risk Study Group
-
Kinoshita Noriyuki
AMl-Kyoto Multi-Center Risk Study Group
-
Keira Natsuya
AMl-Kyoto Multi-Center Risk Study Group
-
Nishio Manabu
AMl-Kyoto Multi-Center Risk Study Group
-
Kimura Shinzo
AMl-Kyoto Multi-Center Risk Study Group
著作論文
- Erythropoietin in Patients With Acute Coronary Syndrome and Its Cardioprotective Action After Percutaneous Coronary Intervention
- PJ-713 Seasonal Mortality Variation in Out-of-hospital Cardiac Arrest : Analysis from AMI-Kyoto Multi-Center Risk Study Database(PJ120,Cardiopulmonary and Critical Care/ACLS (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese
- PJ-383 Predictors of In-Hospital Prognosis after Primary Percutaneous Coronary Intervention for Repeat Myocardial Infarction : Insights from the AMI-Kyoto Multi-Center Risk Study(PJ065,ACS/AMI (Clinical/Treatment) 3 (IHD),Poster Session (Japanese),The 73r
- PE-460 Prehospital Delay Time and the Rate of Ambulance User for Acute Myocardial Infarction were not Improved from 2000-2007 in Kyoto(PE077,ACS/AMI (Clinical/Diagnosis) 1 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese C
- New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Chymase as an Important Target to Prevent Organ Damage
- A case of Takayasu's arteritis and aortic regurgitation, which presented much difficulty in the diagnosing process because of complicated osteomyelitis and non-typical manifestations
- FRS-036 In-hospital Prognostic Value of Crude Peak Creatine Kinase Measurement after Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction(FRS8,Novel Biomarkers and Pathophysiology of ACS (IHD),Featured Research Session (English),The
- Predictors of In-Hospital Outcome After Primary Percutaneous Coronary Intervention for Recurrent Myocardial Infarction
- Effects of Hospital Volume of Primary Percutaneous Coronary Interventions on Angiographic Results and In-Hospital Outcomes for Acute Myocardial Infarction
- OJ-204 Diminished Relation Between Hospital Volume of Primary PCI and In-Hospital Outcomes After AMI : Insights from the AMI-Kyoto Multi-Center Risk Study(Acute myocardial infarction, clinical (diagnosis / treatment)(04)(IHD),Oral Presentation (Japanese),
- Predictors of In-Hospital Prognosis After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Requiring Mechanical Support Devices
- PJ-588 Rehabilitation after Angiogenic Cell Therapy for the Critical Limb Ischemia(PJ099,Exercise Test/Cardiac Rehabilitation 2 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-461 Aerobic Exercise in the Postoperative Cardiac Rehabilitation did not Deteriorate Renal Function in the Patients with Renal Failure(PJ078,Kidney/Renal Circulation/CKD 4 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese
- OJ-023 Intermediate Fixed Coronary Stenosis at a Site of Ergonovine-Provoked Spasm as a Predictor of the Long-Term MACE of CSA Patients(OJ04,Angina Pectoris (Basic, Clinical) (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Jap
- Long-Term Angiotensin II Blockade May Improve Not Only Hyperglycemia but Also Age-Associated Cardiac Fibrosis
- PE-354 Aortic Valve Thickness Depends on Cardiac ACE Activity, not Blood Pressure in 1K-, 1K1C-, and 2K1C-Rabbit Models(PE060,Valvular Heart Disease (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PE-172 Introduction of Training Program in Basic Life Support can Improve the Survival after In-Hospital Cardiopulmonary Resuscitation(PE029,Cardiopulmonary and Critical Care/ACLS (H),Poster Session (English),The 73rd Annual Scientific Meeting of The Japa
- OE-244 Protruding Atheroma in the Thoracic Aorta Detected by Multislice Computed Tomography Can Predict the Major Vascular Events(OE42,CT/MRI (Coronary/Vascular) 2 (I),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulat
- OE-235 Evidence of Plaque Neovascularization and Effects of Angiotensin Receptor Blocker in Cholesterol-Fed Monkey(OE40,Atherosclerosis, Basic 2 (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PE-441 Virtual Histology Assessment of Attenuation Image Detected With 40MHz Gray-scale IVUS
- OE-307 Imidapril Attenuates MMP-9 Level More Effectively than Losartan in Patients with Acute Myocardial Infarction Treated by Primary-Percutaneous Coronary Intervention(Acute myocardial infarction, clinical(diagnosis/treatment)(02)(IHD),Oral Presentation
- PE-317 Angiotensin Receptor 1 Blocker Inhibits Atherosclerotic Changes of Aortic Valve by Preserving Endothelial Cells and Inhibiting Transformation into Osteoblast Phenotype(Vascular heart disease/Pericarditis/Cardiac tumor-2 (M) PE53,Poster Session (Eng
- Evidence for Abundant Presence of Chymase-Positive Mast Cells in the Kidneys of Patients with Immunoglobulin A Nephropathy : Effect of Combination Therapy with Prednisolone and Angiotensin II Receptor Blocker Valsartan
- Nephrogenic diabetes insipidus due to hydronephrosis in a patient with a solitary kidney
- An Insulinoma for which Secretin Test and Selective Arterial Calcium Injection Test were Useful
- Complete Adrenocorticotropin Deficiency after Radiation Therapy for Brain Tumor with a Normal Growth Hormone Reserve
- Creatinine Clearance as a Substitute for the Glomerular Filtration Rate in the Assessment of Glomerular Hemodynamics
- Central Diabetes Insipidus Associated with a Missense Mutation in the Arginine Vasopressin Gene that Replaces Ala at the Carboxyterminus of the Signal Peptide with Thr
- Peliosis Hepatis Associated with Idiopathic Restrictive Cardiomyopathy
- Inhibition of Human Chymase by Suramin
- IS005 Vascular Smooth Muscle Cell(VSMC)-Specific Overexpression of Angiotensin type2(AT2)Receptor Causes Endothelium-dependent Vasodilation via bradykinin/NO/cGMP pathway
- Inhibition of the Angiotensin II Type 1 Receptor by TCV-116: Quantitation by In Vitro Autoradiography
- P218 INTERACTION OF VASCULAR SMOOTH MUSCLE CELLS(VSMC) WITH EXTRACELLULAR MATRIX(ECM) : EFFECTS OF THE PURIFIED HUMAN CHYMASE ON VSMC ATTACHMENT TO ECM
- Intermediate Fixed Coronary Artery Stenosis at the Site of Ergonovine-Provoked Spasm as a Predictor of Long-Term Major Adverse Cardiac Events of Patients With Coronary Spastic Angina
- Chymase inhibition attenuates tetrachloride-induced liver fibrosis in hamsters
- Chymase inhibitor prevents the nonalcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet
- Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats
- Anti-Atherosclerotic Effects of Dihomo-γ-Linolenic Acid in ApoE-Deficient Mice
- Chymase Inhibition Provides Pancreatic Islet Protection in Hamsters With Streptozotocin-Induced Diabetes
- Involvement of Vascular Angiotensin II-Forming Enzymes in the Progression of Aortic Abdominal Aneurysms in Angiotensin II-Infused ApoE-Deficient Mice
- Significance of chymase-dependent angiotensin II formation in the progression of human liver fibrosis
- Characterization of Recombinant Human Chymase Expressed in Escherichia coli
- OJ-062 Effect of Chymase Inhibition by NK-3201 on Hypoxia-Induced Left Ventricular Remodeling in Mice(Cardiovascular pharmacology, basic/clinical(02)(H),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- The Significance of Chymase in the Progression of Abdominal Aortic Aneurysms in Dogs
- OJ-199 Role of Chymase and MMPs in Angiotensin II-induced Abdominal Aortic Aneurysms(Atherosclerosis, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- The Effects of Chymase on Matrix Metalloproteinase-2 Activation in Neointimal Hyperplasia after Balloon Injury in Dogs
- Tissue Angiotensin II Generating System by Angiotensin-Converting Enzyme and Chymase
- PJ-418 Effects of Chymase Inhibition on the Stenosis after Polytetrafluoroethylene Grafts Implantation(Restenosis, basic/clinical-5 (IHD) PJ71,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- PE-278 Chymase Inhibition Prevents the Progression of Abdominal Aortic Aneurysm in Dogs(Peripheral circulation-5 (H) PE47,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Chymase Inhibition Prevents Cardiac Fibrosis and Dysfunction after Myocardial Infarction in Rats
- Role of Chymase-Dependent Angiotensin II Formation in Regulating Blood Pressure in Spontaneously Hypertensive Rats
- The Effect of Chymase Inhibition on Arteriovenous Fistula Stenosis in Dogs (Peripheral Circulation/Vascular Disease 6 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- A Potent Chymase Inhibitor, Suc-Val-Pro-Phe(p)(OPh)(2), Suppresses the Development of Abdominal Aortic Aneurysm in Dogs(Valvular Heart Disease/Pericarditis/Cardiac Tumor 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Effect of Chymase-Dependent Transforming Growth Factor β on Peritoneal Adhesion Formation in a Rat Model
- A Single Treatment With a Specific Chymase Inhibitor, TY-51184, Prevents Vascular Proliferation in Canine Grafted Veins
- PJ-043 An Antiarrhythmic Effect of A Chymase Inhibitor After Myocardial Infarction(Acute Myocardial Infarction, Basic 2 (IHD) : PJ8)(Poster Session (Japanese))
- Impact of Chymase Inhibitor on Cardiac Function and Survival after Myocardial Infarction
- Oral Administration of a Specific Chymase Inhibitor, NK3201, Suppresses the Development of Aneurysmal Dilatation on Hamster Experimental Aneurysm Model
- Possible Roles of Angiotensin II-Forming Enzymes, Angiotensin Converting Enzyme and Chymase-like Enzyme, in the Human Aneurysmal Aorta
- Effect of Chymase Inhibitor on Vascular Proliferation
- Development of the Chymase Inhibitor as an Anti-Tissue-Remodeling Drug : Myocardial Infarction and Some Other Possibilities
- Recombinant Human Chymase Produced by Silkworm-Baculovirus Expression System : Its Application for a Chymase Detection Kit
- Oral Administration of a Novel Chymase Inhibitor, NK3201, Prevents Peritoneal Adhesion Formation in Hamsters
- Inhibition of chymase improves cardiac function via suppression of fibrosis in hamster cardiomyopathic model
- Role of chymase in the development of aneurysmal formation; An experimental aneurysm model
- Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Adriamycin-Induced Cardiomyopathy in Hamsters
- Possible Roles of Cardiac Chymase After Myocardial Infarction in Hamster Hearts
- An Orally Active Chymase Inhibitor, BCEAB, Suppresses Heart Chymase Activity in the Hamster
- The Functional Ratio of Chymase and Angiotensin Converting Enzyme in Angiotensin I-Induced Vascular Contraction in Monkeys, Dogs and Rats
- Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts
- PJ-333 Impact of Clinical Path on Self Esteem to Modify Lifestyle in Patients Undergoing Cardiac Catheterization : Using Questionnaire about Lifestyle(PJ056,Preventive Medicine/Epidemiology/Education 2 (H),Poster Session (Japanese),The 73rd Annual Scienti
- PE-549 Different Acute Effect of Continuous Positive Airway Pressure on Morning Blood Pressure in Obstructive Sleep Apnea(Hypertension, clinical(06)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Trans-Differentiation of Bone Marrow Monocyte-Lineage Cells to Endothelial-Like Cells and Reendothelialization on Injured Endothelium by MCP-1-Dependent Adhesion
- Characteristics of Monkey Tryptase Purified From Cheek Pouch Vascular Tissues
- PE-398 Nuclear Factor-κ B Activation Accelerates Cardiac Hypertrophy, Interstitial Fibrosis, and Oxidative Stress in Diabetic Rats Exposed to Intermittent Hypoxia(Chronic coronary heart disease/Remodeling-2, The 71st Annual Scientific Meeting of the Japan
- G-CSF Treatment Inhibits Neointimal Hyperplasia Associated with Endothelial Progenitor Cell Mobilization and Acceleration of Reendothelialization in Catorid Artery Injuty Model(Restenosis after Angioplasty, Basic/Clinical 5 (IHD), The 69th Annual Scientif
- Critical Role of Tyrosine Kinase PYK2 in eNOS Activation Revealed by Analysis of PYK2 Knockout Mice(Endothelium/NO 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-417 Tyrosine Kinase PYK2 activates eNOS and subsequently regulates Vascular Tonus and Angiogenesis, revealed by its Knock-out Mice(Endothelium/NO 5 (H) : OJ51)(Oral Presentation (Japanese))
- eNOS Activation and Its Vascular Functions Critically Requires the Presence of Tyrosine Kinase PYK2
- OJ-028 G-CSF Treatment Inhibits Neointimal Formation after Arterial Injury through the Mobilization of Endothelial Progenitor Cell and Acceleration of Reendothelialization(Restenosis, basic/clinical-1 (IHD) OJ5,Oral Presentation (Japanese),The 70th Annive
- Inhibition of Vascular Angiotensin-Converting Enzyme by Telmisartan via the Peroxisome Proliferator-Activated Receptor γ Agonistic Property in Rats
- Inhibition of Matrix Metalloproteinase-9 Activity by Trandolapril after Middle Cerebral Artery Occlusion in Rats
- Predictors of nonoptimal coronary flow after primary percutaneous coronary intervention with stent implantation for acute myocardial infarction
- Erythropoietin Prevention Trial of Coronary Restenosis and Cardiac Remodeling After ST-Elevated Acute Myocardial Infarction (EPOC-AMI) : A Pilot, Randomized, Placebo-Controlled Study
- Influence of previous myocardial infarction site on in-hospital outcome after primary percutaneous coronary intervention for repeat myocardial infarction
- 我が国における子馬のロドコッカス・エクイ感染症の疫学調査--1992年から1998年の108症例
- Trandolapril Reduces Infarction Area after Middle Cerebral Artery Occlusion in Rats
- Effects of a Lipoxygenase Inhibitor, Panaxynol, on Vascular Contraction Induced by Angiotensin II
- SOME EXPERIMENTS ON ASCENDING OF CORYNEBACTERIUM RENALE IN MICE FROM URINARY BLADDER INTO KIDNEYS
- ISOLATION OF NON-PILIATED CLONE OF CORYNEBACTERIUM RENALE STRAIN 115
- Significance of Angiotensin II Receptor Blocker Lipophilicities and Their Protective Effect against Vascular Remodeling
- Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats
- Genotypic Characterization of Virulent Rhodococcus equi Isolated from the Environment of Hokkaido Native Horses in Hakodate, Hokkaido
- Comparative Effects of Candesartan and Amlodipine in a Monkey Atherosclerotic Model
- Significant Target Organs for Hypertension and Cardiac Hypertrophy by Angiotensin-Converting Enzyme Inhibitors
- Significance of Vascular Angiotensin-Converting Enzyme in the Depressor Mechanism by Angiotensin-Converting Enzyme Inhibitors
- Pharmacological Profiles of a Novel Non-peptide Angiotensin II Type I Receptor Antagonist HR720 In Vitro and In Vivo
- Cloning and Characterization of the fur Gene From Moraxella bovis
- Expression of Virulence-Associated Antigens of Rhodococcus equi Is Regulated by Temperature and pH
- Rhodococcus qui Infection in Foals -Current Concepts and Implication for Future Research-
- VapB-positive Rhodococcus equi infection in an HIV-infected patient in Japan
- Transient Central Diabetes Insipidus in Pregnancy with a Peculiar Change in Signal Intensity on T1-Weighted : Magnetic Resonance Images
- Treatment of Lymphocytic Hypophysitis by High-Dose Methylprednisolone Pulse Therapy
- Clinical manifestations and effects of primary percutaneous coronary intervention for patients with delayed pre-hospital time in acute myocardial infarction
- Irbesartan Prevents Metabolic Syndrome in Rats via Activation of Peroxisome Proliferator-Activated Receptor γ
- New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System : Chymase as an Important Target to Prevent Organ Damage
- Enhanced Cardiovascular Protective Effects of Valsartan in High-Risk Hypertensive Patients With Left Ventricular Hypertrophy : Sub-Analysis of the KYOTO HEART Study
- Antiatherosclerotic Effect of Alacepril, an Angiotensin : Converting Enzyme Inhibitor, in Monkeys Fed a High-Cholesterol Diet
- Irbesartan Prevents Metabolic Syndrome in Rats via Activation of Peroxisome Proliferator-Activated Receptor γ
- Multiple Mechanisms for the Action of Chymase Inhibitors
- Outside Fibroblasts Play a Key Role in the Development of Inner Neointima After the Implantation of Polytetrafluoroethylene Grafts